We are live on ! Find out more
CC

Cannell & Co Portfolio holdings

AUM $3.15B
1-Year Est. Return 30.62%
This Fund
S&P 500
This Quarter Est. Return
-10.13%
1 Year Est. Return
+30.62%
3 Year Est. Return
+51.59%
5 Year Est. Return
+187.25%
10 Year Est. Return
+311.51%
AUM
$3.08B
AUM Growth
-$454M
Cap. Flow
-$10.5M
Cap. Flow %
-0.34%
Top 10 Hldgs %
30.04%
Holding
290
New
20
Increased
70
Reduced
90
Closed
22

Top Buys

1
VISN
Vistance Networks Inc
VISN
+$65.5M
2
WT icon
WisdomTree
WT
+$46M
3
BWLD
Buffalo Wild Wings, Inc.
BWLD
+$34.7M
4
PLD icon
Prologis
PLD
+$23.9M
5
GS icon
Goldman Sachs
GS
+$23.5M

Top Sells

1
PARA
Paramount Global Class B
PARA
+$69.9M
2
WHR icon
Whirlpool
WHR
+$51.8M
3
HRB icon
H&R Block
HRB
+$37.9M
4
WPC icon
W.P. Carey
WPC
+$26.3M
5
CELG
Celgene Corp
CELG
+$25.3M

Sector Composition

1 Healthcare 21.57%
2 Industrials 19.91%
3 Technology 14.58%
4 Financials 10.22%
5 Energy 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CELGZ
201
DELISTED
Celgene Corporation Contingent Value Rights
CELGZ
$538K 0.02%
333,865
– –
WPM icon
202
Wheaton Precious Metals
WPM
$46.9B
$516K 0.02%
43,000
– –
WMT icon
203
Walmart Inc
WMT
$913B
$497K 0.02%
22,980
– –
YUM icon
204
Yum! Brands
YUM
$41.1B
$492K 0.02%
8,555
-67,533
-89% -$4.09M
CERS icon
205
Cerus
CERS
$613M
$477K 0.02%
105,000
– –
MCD icon
206
McDonald's
MCD
$190B
$477K 0.02%
4,843
– –
ZBH icon
207
Zimmer Biomet
ZBH
$17.7B
$470K 0.02%
5,149
– –
TEVA icon
208
Teva Pharmaceuticals
TEVA
$37.3B
$468K 0.02%
8,284
– –
OEF icon
209
iShares S&P 100 ETF
OEF
$20.1B
$451K 0.01%
5,323
– –
ENLC
210
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$446K 0.01%
24,400
– –
CFR icon
211
Cullen/Frost Bankers
CFR
$10.1B
$443K 0.01%
6,970
– –
LGCY
212
DELISTED
Legacy Reserves Inc. Common Stock
LGCY
$434K 0.01%
106,100
+23,325
+28% +$158K
INGR icon
213
Ingredion
INGR
$6.45B
$423K 0.01%
4,850
– –
ED icon
214
Consolidated Edison
ED
$41.2B
$419K 0.01%
6,268
– –
TSLA icon
215
Tesla
TSLA
$1.43T
$405K 0.01%
24,450
– –
PRE
216
DELISTED
PARTNERRE LTD
PRE
$403K 0.01%
2,900
– –
NFLX icon
217
Netflix
NFLX
$290B
$397K 0.01%
38,450
+11,850
+45% +$127K
GIS icon
218
General Mills
GIS
$20.3B
$394K 0.01%
7,025
– –
WTRG icon
219
Essential Utilities
WTRG
$11.2B
$386K 0.01%
14,575
-200
-1% -$5.12K
FWONK icon
220
Liberty Media Series C
FWONK
$25.5B
$381K 0.01%
15,608
-3,029
-16% -$77.7K
AMZN icon
221
Amazon
AMZN
$2.66T
$369K 0.01%
14,400
– –
SKT icon
222
Tanger
SKT
$4.78B
$369K 0.01%
11,200
– –
SNA icon
223
Snap-on
SNA
$21.2B
$358K 0.01%
2,375
– –
GLD icon
224
SPDR Gold Trust
GLD
$129B
$347K 0.01%
3,250
+1,000
+44% +$108K
ORCL icon
225
Oracle
ORCL
$362B
$345K 0.01%
9,550
– –
7 8
9
10 11

Similar funds

GW
GW & Wade Wellesley, Massachusetts $3.08B AUM 18.99% 1-Year Est. Return
PMEF
Point72 Middle East FZE Dubai, United Arab Emirates $3.38B AUM 14.09% 1-Year Est. Return
SS
Simplicity Solutions Minneapolis, Minnesota $3.66B AUM 23.51% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
WP
WealthSource Partners San Luis Obispo, California $1.54B AUM 16.68% 1-Year Est. Return
BWM
Baystate Wealth Management Boston, Massachusetts $1.36B AUM 15.87% 1-Year Est. Return
DI
DFPG Investments Sandy, Utah $1.28B AUM 27.55% 1-Year Est. Return

Cannell & Co's Q3 2015 Portfolio in Review

As of Q3 2015, Cannell & Co held 290 positions worth $3.08B, down 13% from $3.53B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Cannell & Co's Q3 2015 filing shows 20 new, 70 increased, 90 reduced and 22 closed positions. Its largest new stake was Vistance Networks Inc: 2,112,135 shares worth $63.4M. The largest sale was Paramount Global Class B, an estimated $69.9M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Industrials and Technology.

  • Cannell & Co's largest Q3 2015 buy was Vistance Networks Inc: 2,112,135 shares worth $63.4M.
  • Cannell & Co added most to WisdomTree in Q3 2015, an estimated $46M increase.
  • Cannell & Co's biggest Q3 2015 reduction was Paramount Global Class B, cutting an estimated $69.9M.
  • Cannell & Co fully exited Intercept Pharmaceuticals, Inc. in Q3 2015, selling an estimated $13.6M.
  • Cannell & Co's ten largest holdings make up 30% of its $3.08B portfolio in Q3 2015.
  • Cannell & Co opened 20 new positions and closed 22 in Q3 2015.
  • Cannell & Co's portfolio value fell 13% quarter-over-quarter to $3.08B.

Based on Cannell & Co's 13F filing for Q3 2015, filed 13 Nov 2015.